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1270 The Journal of Thoracic and CardObjective: The study’s objective was to identify predictors of prolonged ventilation
and assess clinical and cost implications in patients undergoing cardiac surgery.
Methods: Patients undergoing cardiac surgery were classified as (1) ventilated less
than 96 hours or (2) ventilated 96 hours or more. Multivariate modeling was used to
identify predictors of prolonged ventilation and to ascertain the impact of prolonged
ventilation on in-hospital mortality and bed occupancy costs and 5-year survival.
Results: A total of 7553 patients were studied; 197 (2.6%) had prolonged ventila-
tion. Median ventilation times were 8 and 192 hours, and in-hospital mortality was
1.0% and 22.2% in the control and prolonged ventilation groups, respectively (P 
.001). In-hospital mortality remained higher in the prolonged ventilation group after
adjustment and when comparing propensity-matched patients (odds ratio 8.06; 95%
confidence interval [CI] 4.27-15.2; P  .001 for propensity-matched groups).
Independent predictors of prolonged ventilation were as follows: older age, New
York Heart Association class, ejection fraction less than 50%, creatinine greater
than 200 mol/L, multiple valve replacements, aortic procedures, operative priority,
reoperation for bleeding, inotropes, and preoperative intra-aortic balloon pump.
Five-year survival was lower in the prolonged ventilation group (56.1% [95% CI
46.6%-64.6%] vs 88.8% [95% CI 87.9%-89.6%]) also after adjustment for imbal-
ances and when comparing propensity-matched patients (hazard ratio 2.39; 95% CI
1.75-3.27; P  .001 for propensity-matched groups). Mean bed occupancy costs
were $14,286 (95% CI $12,731-$15,690) and $2761 (95% CI $2705-$2814) in the
prolonged ventilation and control groups, respectively (P  .001).
Conclusion: Prolonged ventilation is associated with high in-hospital mortality and
costs, and poor 5-year survival. Identified predictors of prolonged ventilation might
help to optimize the clinical management of these patients.
Over the past years there has been a renewed interest on cost containment byhealth care system producers.1 Evidence has emerged suggesting that earlyextubation after cardiac surgery reduces the length of intensive care unit
(ICU) and hospital stay, minimizing costs without compromising patients’ clinical
outcomes.1-5 Conversely, prolonged ventilation (PV) may have an important impact
on costs.1 The burden on hospital resources of patients requiring a prolonged ICU
stay is enormous, and it has also important indirect implications such as cancelations
of the routine operative list.
This study determines the independent predictors of PV and its economic
implications in patients undergoing cardiac surgery. We ascertain the in-hospital
and midterm mortality of patients requiring PV after cardiac surgery.
Methods
Patient Selection
Data were extracted on a cohort of 7553 consecutive adult patients who underwent cardiac
surgery between April 1996 and March 2003 at our institution. PV was defined as any patient
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continuously or in total after reintubation. Patients who were
ventilated throughout and died within 96 hours of surgery were
excluded because they did not fit naturally into either group. A
standard set of perioperative data are collected prospectively for all
patients undergoing cardiac surgery at our institution. The data set
comprises 5 sections, completed consecutively by the anesthetist,
surgeon, ICU, high-dependency unit (HDU), and ward nurses.
Data are entered into the Patient Analysis and Tracking Systems
database (Dentrite Clinical Systems, London, United Kingdom).
Anesthetic and Surgical Technique
Anesthetic and surgical techniques were as reported previously.6-8
Briefly, heparin was given intravenously at a dose of 300 IU/kg,
with additional intravenous doses of 3000 IU to maintain the
activated clotting time more than 480 seconds throughout cardio-
pulmonary bypass (CPB). A standard CPB circuit was used. Non-
pulsatile flow was used, with a flow rate throughout bypass of 2.4 L
· min · m. Mean arterial pressure was maintained at 50 to 60 mm Hg
during CPB.
For conventional coronary artery bypass grafting operations,
systemic temperature was maintained between 34°C and 36°C.
Myocardial protection was achieved using intermittent antegrade
warm blood cardioplegia. For all other operations, myocardial
protection was predominantly by a combination of intermittent
antegrade and retrograde cold blood cardioplegia, with moderate
systemic hypothermia to 28°C to 32°C. With aortic surgery, in
which deep hypothermic circulatory arrest was required, the target
cooling temperature was 18°C, and cerebral protection was as
previously reported.8 The technique used for off-pump coronary
artery bypass procedures has been reported.9 Briefly, the target
vessel was exposed and temporarily snared above the anastomotic
site using a 4-0 Prolene suture (Ethicon, Inc, Somerville, NJ) with
a soft plastic snugger. The coronary artery was then opened, an
intracoronary shunt was systematically used, and the anastomosis
was performed using a pressure stabilizer.
ICU Management
At the end of the operation, patients were transferred to the ICU.
The lungs were ventilated with 60% oxygen using volume-
controlled ventilation. Adjustments in FIO2 and respiratory rate
were made according to routine blood gas analysis, to maintain
PaO2 between 80 and 100 mm Hg, and PaCO2 between 35 and 40
mm Hg. Forced air warming was used until a stable nasopharyn-
geal temperature of 37°C had been reached. The decision to
Abbreviations and Acronyms
CI  confidence interval
CPB  cardiopulmonary bypass
HDU  high-dependency unit
ICU  intensive care unit
NSTS  National Strategic Tracing Service
NYHA New York Heart Association
PV  prolonged ventilationextubate a patient is at the independent discretion of the consultant
The Journal of Thoracicanesthetist and follows a predefined protocol, aiming at early
extubation. Once the patient is warmed to 36°C, weaning is com-
menced by terminating any sedative drug infusions. A systolic
blood pressure greater than 100 mm Hg and pulse rate less than
100 beats/min are aimed for. The blood loss must be less than 100
mL/h and decreasing from the chest drains. Arterial blood gas
analysis must reveal a pH of 7.35 to 7.5, PCO2 35 to 49 mm Hg, and
PO2 greater than 90 mm Hg on an inspired oxygen concentration of
50% or less, base excess –3 to 3. Before extubation the patient
must be neurologically alert and orientated with equal movement
throughout all limbs, initiating adequate respiration and obeying
commands. At the discretion of the consultant intensivist and
according to the described protocol, elective patients are amenable
to nurse extubation.
Decisions about transfers from the ICU to the HDU and from
the HDU to the ward, and vice versa, are made by intensivists on
the basis of predefined protocols. Extubated patients who require
continuous monitoring of either blood pressure or urine output, or
prolonged chest physiotherapy are moved to the HDU. The nurse/
patient ratio at this level is 1:2, whereas it is 1:1 in the ICU and 1:4
at the ward level.
Bed Occupancy Cost
Costs were calculated according to nursing shifts (three 8-hour
shift periods per day) at each dependency level. The cost was
therefore calculated from respective shift rates and length of stay
at each dependency level and included both the cost of maintaining
the bed and nursing cost. The shift rate costs were $242.82 for an
ICU bed, $123.35 for an HDU bed, and $60.71 for a ward bed.
Suitability for discharge from the ICU and HDU followed unit pro-
tocol and was based on the judgment of an independent intensivist.
Follow-up
Postdischarge mortality data were obtained from the UK National
Strategic Tracing Service (NSTS) in October 2004, and 99.5% of
the study cohort was successfully matched to the NSTS database.
Because most deaths are reported to NSTS within 2 months of the
event, the survival time was calculated from the date of surgery to
July 31, 2004, for surviving patients. For the patients who could
not be traced through NSTS, the survival time was censored at
hospital discharge.
Statistical Analysis
Data are reported as number and percentage (categoric data); mean
and standard deviation (normally distributed continuous vari-
ables); or median and interquartile range (continuous variables
with a skewed distribution). Baseline characteristics were com-
pared using the chi-square or Fisher exact test (categorical vari-
ables) or the Wilcoxon rank-sum test (continuous or discretely
measured variables). Patients with 3 or more baseline demographic
or clinical data items missing were excluded from all analyses.
Predictors of PV were identified using backward stepwise
logistic regression. Variables significant at the 10% level or less
(likelihood ratio test) were retained. Model calibration and dis-
criminatory ability were assessed using the Hosmer-Lemeshow
test and the c-statistic, respectively. Candidate variables included
factors believed to be important clinically plus those preoperative
and Cardiovascular Surgery ● Volume 130, Number 5 1271
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Variable Control group (n  7356) % (97.4) PV group (n  197) % (2.6) P value
Age (y) 65 (58-71) 68 (62-73) .0002
Body mass index (kg/m2) 26.4 (23.8-29.2) 24.8 (21.1-27.7) .0001
Female gender 1779 (24.2) 59 (29.9) .063
Dyspnea class
NYHA I 1424 (19.3) 33 (16.8) .001
NYHA II 3034 (41.3) 35 (17.8)
NYHA III 2394 (32.6) 66 (33.5)
NYHA IV 501 (6.8) 63 (31.9)
Canadian Cardiovascular Society score
CCS 0/1 1622 (22.1) 84 (42.6) .001
CCS 2 1996 (27.1) 27 (13.7)
CCS 3 2094 (28.5) 38 (19.3)
CCS 4 1641 (22.3) 48 (24.4)
Parsonnet score 7 (3-13) 19 (12-29) .0001
Congestive heart failure 1309 (17.8) 85 (43.3) .001
Previous MI
1 2085 (28.4) 57 (28.9) .78
2 476 (6.5) 15 (7.6)
Timing of previous MI
1 mo 304 (4.2) 24 (12.2) .001
1 mo 2239 (30.5) 48 (24.8)
Hypertension 3952 (53.8) 94 (47.7) .093
Diabetic 1068 (14.5) 25 (12.7) .47
Hypercholesterolemic 4596 (62.6) 74 (37.8) .001
Respiratory condition
COPD 371 (5.1) 15 (7.6) .054
Asthma 362 (4.9) 15 (7.6)
Smoking history 5040 (68.5) 120 (60.9) .023
Renal dysfunction* 146 (2.0) 26 (13.2) .001
Extent of coronary disease
Normal 1192 (16.4) 60 (31.4) .001
1 vessel 649 (8.9) 13 (6.8)
2 vessels 1508 (20.8) 30 (15.7)
3 vessels 3869 (53.4) 76 (39.8)
Not investigated 34 (0.5) 12 (6.3)
Moderate or poor ejection fraction† (50%) 2095 (28.6) 91 (47.4) .001
Previous surgery 337 (4.6) 21 (10.6) .001
Preoperative inotropes 36 (0.5) 33 (16.8) .001
Ventilated 21 (0.3) 14 (7.1) .001
Preoperative intra-aortic balloon pump 33 (0.5) 24 (12.2) .001
Operative priority
Elective 3340 (45.4) 53 (26.9) .001
Urgent 3821 (52.0) 82 (41.6)
Emergency 176 (2.4) 54 (27.4)
Salvage 15 (0.2) 8 (4.1)
Type of operation
CABG 5430 (73.8) 66 (33.5) .001
CABG - OPCAB 1759 (32.4) 16 (24.2)
Valve 1079 (14.7) 38 (19.3)
Valve  CABG 523 (7.1) 30 (15.3)
Aortic surgery 208 (2.8) 43 (21.8)
Other combined procedures 116 (1.6) 20 (10.1)
PV, Prolonged ventilation; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Score; MI, myocardial infarction; COPD, chronic obstructive
pulmonary disease; OPCAB, off-pump coronary artery bypass; CABG, coronary artery bypass graft. *Serum creatinine 200 mol/L or either acute or
chronic renal failure requiring dialysis. †Moderate ejection fraction, 30% to 49%; poor ejection fraction, 30%.
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icant imbalance between the groups.
In-hospital morbidity is reported without adjustment for differ-
ences between the control and PV groups because it is not possible
to separate cause and effect; most complications occur while the
patient is ventilated and before the classification to control or PV
group can be made. In contrast, in-hospital mortality and 5-year
survival in the control and PV groups are reported with and without
adjustment for potential confounding variables. The variables in-
cluded in the adjustment were specified in advance of the analysis,
and no attempt was made to assess their statistical significance, either
individually or together (see footnote to Table 3 for details).
Confirmatory analyses, comparing outcomes for the PV group and
a propensity-matched group of control patients (up to 5 matched
controls selected per patient in PV group), were also carried out.
TABLE 2. In-hospital outcomes
Variable Control group (n
In-hospital death 73
Perioperative MI 137
Atrial fibrillation 1138
Chest infection 393
Reintubated 159
Tracheostomy 63
Permanent stroke 44
Transient ischemic attack 45
Sternal rewiring 56
Septicemia 86
Renal dysfunction† 76
Gastrointestinal complications 82
Multisystem failure 34
Reoperation for bleeding/tamponade 290
2921
2 (1-3)
Patients requiring fresh-frozen plasma* 901
4 (2-4)
Patients requiring platelets* 1122
1 (1-2)
ICU stay (d) 1 (1-2)
HDU stay (d) 1 (1-2)
Ward stay 4 (3-6)
PV, Prolonged ventilation; MI, myocardial infarction; ICU, intensive care uni
1997. †Serum creatinine 200 mol/L or either acute or chronic renal fa
TABLE 3. Effect sizes (95% confidence interval): In-hospita
Variable Unadj
In-hospital death 28.7 (20
Survival to 5 y (excluding in-hospital deaths) 5.13 (3.
*Robust CIs clustered by consultant team. Adjustment included age, ge
congestive cardiac failure, previous myocardial infarction, diabetes, sm
coronary disease, hypercholesterolemia, previous surgery, ejection fra
preoperatively, operative priority, valve procedures, aortic procedure, CAB
postoperative bleed. †Robust CIs clustered by matched PV-control group;
was not found. The other 183 patients in the PV group were matched to betwe
The Journal of ThoracicPatient and operative variables included in the adjusted analyses
were used to calculate the propensity score, and a greedy algorithm
was used to select the matched pairs. Standard regression methods
were used: logistic regression for in-hospital mortality and Cox
proportional hazards regression for 5-year survival. Model as-
sumptions were checked, and where they were untenable alterna-
tive models were explored. All analyses calculated robust confi-
dence intervals (CIs), taking account of clustering of patients.
Results are reported with 95% CIs. No correction was made for the
number of outcomes compared. Our interpretation of the findings
is based on the consistency of the findings and their magnitude as
well as their statistical significance.
Ninety-five percent CIs for the mean economic costs were
calculated from 100 bootstrap samples and are based on percen-
tiles of the bootstrap estimates obtained. This method was chosen
56) % PV group (n  197) %
(1.0) 44 (22.3)
(1.9) 9 (4.6)
(15.5) 120 (60.9)
(5.3) 93 (47.2)
(2.2) 78 (39.6)
(0.9) 115 (58.4)
(0.6) 16 (8.3)
(0.6) 17 (8.7)
(0.8) 10 (5.1)
(1.2) 83 (42.8)
(1.0) 73 (37.0)
(1.1) 44 (22.2)
(0.5) 61 (31.1)
(4.0) 41 (20.8)
(46.1) 161 (96.9)
7 (4-11)
(14.3) 101 (62.7)
4 (3-8)
(17.8) 106 (64.2)
2 (1-3)
14 (7-23)
4 (2-7)
6 (3-10)
, high-dependency unit. *Transfusion data were not collected before April
ialysis.
rtality and 5-year survival
Adjusted* Propensity matched†
.6) 7.48 (4.56-12.3) 8.06 (4.27-15.2)
1) 2.48 (2.02-3.02) 2.39 (1.75-3.27)
, body mass index, NYHA and Canadian Cardiovascular Score classes,
history, respiratory problem, renal dysfunction, hypertension, extent of
50%, ventilation, inotropes and an intra-aortic balloon pump used
uble thoracic graft, use of CPB and prolonged CPB time 90 minutes, and
tients in PV group were excluded because a propensity-matched control 73
t; HDUl mo
usted
.3-40
70-7.1
nder
oking
ction
G, do
14 paen 2 and 5 control patients (mean 4.5).
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followed a highly skewed distribution.
Analyses were performed using Stata version 8.2 (Stata Cor-
poration, College Station, Tex).
Results
Seventy patients (including 28 emergency or salvage cases)
who were ventilated throughout and died within 96 hours of
surgery were excluded. Of these, 42 died within the first 24
hours postsurgery. A total of 197 patients, 2.6% of the study
population (59 women, median age 68 years, interquartile
range 62-73), were ventilated for 96 hours or longer, 119
(59.4%) continuously and 78 (40.6%) in total after reintu-
bation. The control group consisted of the remaining 7356
patients (97.4%). Median ventilation times were 8 and 192
hours in the control and PV groups, respectively. Preoper-
ative characteristics and types of surgery for both groups are
shown in Table 1. On average, patients in the PV group
were older and more likely to have had a recent myocardial
TABLE 4. Independent risk factors for prolonged ventila-
tion
Variable
Multivariate
odds ratio 95% CI P value
Age (y)
55 1.00 .001
55-59 1.25 1.15-1.37
60-64 1.58 1.32-1.89
65-70 1.99 1.53-2.59
71-89 2.50 1.76-3.56
NYHA
Class I 1.00 .001
Class II 0.81 0.60-1.06
Class II 1.72 1.16-2.55
Class IV 3.41 2.28-5.10
Moderate or poor ejection
fraction (50%)*
1.55 1.03-2.33 .034
Renal dysfunction† 3.01 2.05-4.43 .001
CPB time 90 min 1.55 1.14-2.11 .004
Double valve procedure 3.22 2.18-4.75 .001
Aortic procedure 8.59 5.25-14.05 .001
Preoperative inotropes 4.50 2.38-8.48 .001
Preoperative intra-aortic
balloon pump
3.65 1.94-6.89 .001
Operative priority
Elective 1.00 .001
Urgent 1.06 0.69-1.64
Emergency 2.89 1.85-4.53
Salvage 4.98 2.37-10.46
Reoperation for bleeding 4.69 2.47-8.92 .001
NYHA, New York Heart Association; CPB, cardiopulmonary bypass; CI,
confidence interval. *Moderate ejection fraction, 30% to 49%; poor ejec-
tion fraction, 30%. †Serum creatinine 200 mol/L or either acute or
chronic renal failure dialysis.infarction, previous cardiac surgery, ejection fraction less
1274 The Journal of Thoracic and Cardiovascular Surgery ● Novthan 50%, congestive heart failure, renal dysfunction, and
advanced New York Heart Association (NYHA) class and
Canadian Cardiovascular Society score. Conversely, control
patients were more likely to have hypercholesterolemia, a
smoking history, and more extensive coronary artery disease.
The in-hospital outcomes are shown in Table 2. The
primary cause of PV was low cardiac output in 92 patients
(46.7%) and pneumonia/chest infection in 29 patients
(14.7%). For the remaining 76 patients (38.6%) the cause
was considered mixed; several complications occurred dur-
ing the first 48 hours postsurgery, but the actual sequence of
events was not recorded. As expected, in-hospital morbidity
was significantly higher in the PV group (P  .001 for all
outcomes). In-hospital mortality was also significantly
higher (1.0% vs 22.3%). The magnitude of the increased risk
of in-hospital death was reduced after adjustment for imbal-
ances between the groups and when comparing propensity-
matched patients, but remained significantly higher for patients
ventilated for 96 hours or more (P  .001, Table 3). More than
60% of all patients had transfusion of blood products, with
96.9% of patients receiving a blood transfusion in the PV
group compared with 46.1% of the control group.
Twenty-eight potential predictors for PV were consid-
ered, and of these age, NYHA class, ejection fraction less
than 50%, renal dysfunction, CPB time more than 90 min-
utes, multiple valve replacements, aortic procedures, use of
preoperative inotropes and intra-aortic balloon pump, oper-
ative priority, and reoperation for bleeding were found to be
independent predictors of PV (Table 4).
Median follow-up for survival was 3.4 (1.7-5.5) years
versus 3.7 (1.7-5.5) years for PV and control groups, re-
spectively. The Kaplan-Meier survival curve is shown in
Figure 1. Five-year Kaplan-Meier survival curve for patients dis-
charged after surgery. ITU, Intensive therapy unit; HDU, high-
dependency unit.Figure 1. The 5-year survival (excluding in-hospital deaths)
ember 2005
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46.6%-64.6%] vs 88.8% [95% CI 87.9%-89.6%]). The
magnitude of the increased risk of death after hospital
discharge was reduced after adjustment for imbalances be-
tween the groups and when comparing propensity-matched
patients but remained significantly higher for patients ven-
tilated for 96 hours or more (P  .001, Table 3).
Distribution of bed occupancy cost between groups is
shown in Figure 2. Mean total bed occupancy costs were
$14,286 (95% CI $12,731-$15,690) and $2761 (95% CI
$2705-$2814) in the PV and control groups, respectively
(P  .001). Patients in the PV group, on average, were
associated with higher ICU and HDU costs (P .0001), but
ward costs were similar across the 2 groups (P  .35).
Although the 197 patients in the PV group represented only
2.6% of the entire population, they accounted for 12.2% of
the total bed occupancy costs.
Discussion
This study has 3 major findings. First, patients experiencing
PV after cardiac surgery have a significantly higher in-
hospital mortality and morbidity and poorer 5-year survival.
Second, this study identifies a list of independent predictors
of PV (see below). Finally, the study reveals that this small
percentage (2.6%) of patients has an enormous impact on
the cardiac surgery unit budget, accounting for 12% of the
total bed occupancy costs.
The mortality and morbidity reported in the literature
seem to depend on the definition of PV, which varies from
24 hours to 14 days.10-13 Our cutoff at 96 hours was chosen
prospectively to include those patients who had more than
transient clinical deterioration. We decided not to consider
other strata (ie, 24 or 48 hours of PV) because this would
detract from the main focus of the study, which is about
patients requiring PV for a long period of time, not attributable
to simple slow recovery or transient minor clinical complica-
tions. The in-hospital mortality of 22.3% in our study is in
keeping with other reports.10,11 Studies that defined PV as
ventilation more than 7 days reported an in-hospital mortality
of 45%;12,13 PV more than 48 hours in 19.6%;11 and PV more
than 24 hours in 18.5%.10 In accordance with other re-
ports,12,13 5-year survival was significantly poorer for the
PV group (56.1% vs 88.8%), and this difference remained
significant even after adjustment for possible confounding
variables and when comparing propensity-matched groups.
Our study identified a list of independent predictors of
PV including increasing age, NYHA class, ejection fraction
less than 50%, renal dysfunction (creatinine 200 mol/L
or dialysis), CPB time more than 90 minutes, multiple valve
replacements, aortic procedures, operative priority, reopera-
tion for bleeding, and need for inotropes or an intra-aortic
balloon pump preoperatively. The value of identifying in-
dependent risk factors is that it may allow preoperative
The Journal of Thoracicoptimization of patients at risk and resource allocation. This
is particularly relevant when considering that, in the future,
the proportion of high-risk patients requiring PV might
increase, because there has been a 30% increase in predicted
operative risk in the past decade.14
Patients with ejection fraction less than 50% were 1.6
times more likely to require PV. In this subgroup the in-
creased metabolic demands of breathing might be inade-
quately supported by the impaired pump function leading to
PV as suggested by others.15,16
Contrary to other studies,10,13,17,18 the presence of
chronic obstructive pulmonary disease or asthma preopera-
tively, and smoking were not found to be associated with
PV. This finding is somehow surprising, because one would
expect PV to be more common in these patients. One
explanation might be that PV is associated with severe,
rather than mild or moderate baseline respiratory dysfunc-
tion. However, this is difficult to ascertain with our study
because of the lack of baseline lung function tests, which
prevents stratifying the analysis by degree of lung dysfunc-
tion and warrants a dedicated prospective study.
Several intraoperative and postoperative factors were
identified as independent predictors of PV. Aortic surgical
procedures carried 8.5 times the risk of PV compared with
other procedures. Higher morbidity and mortality after aor-
tic procedures are commonly associated with neurologic
complications, the incidence of which is reported to vary
from 5% to 70%.19 Also, these procedures often require
prolonged CPB, a further independent predictor of PV in
our study.
A staggering 12.2% of our total bed occupancy costs
have been dedicated to caring for 2.6% of patients. The cost
Figure 2. Distribution of bed occupancy cost between groups. PV,
Prolonged ventilation.of caring for patients who require PV might be grossly
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practical perspective, and on the basis of bed occupancy costs
alone, the 197 patients in the PV group cost the equivalent
of more than 1000 routine patients. We are not implying,
however, that patients predicted to require PV should be
denied their operation. In fact, more than 50% of patients in
the PV group survived to 4 years after the operation in our
series.
There are a number of implications arising from the
findings of our study. Predicting the likely occurrence of PV
could help optimize the preoperative patient information
and consenting process, patient management, and case-mix
scheduling. First, because the right of cure of each patient
is coupled with his or her right to be fully informed, the
information provided by our study might help surgeons
better inform their patients about the risk/benefit balance
associated with the intended surgical procedure. Second,
some of the predictors of PV identified, including creatinine
greater than 200 mol/L, operative priority, and reoperation
for bleeding, may be managed differently to minimize their
impact on clinical outcome. It has been suggested that
preoperative volume depletion and recent administration of
nephrotoxic drugs in patients with serum creatinine greater
than 200 mol/L enhance acute renal failure, a recognized
independent predictor of in-hospital death.20 As a result, at
our institution we have started to use preoperative (12
hours) volume replacement therapy in patients with mild to
moderate renal insufficiency and have adopted a more crit-
ical approach to preoperative radiographic contrast agents
exposure scheduling. With regard to operative priority, up
to 50% of our patients were urgent referrals (48% in the PV
group), which, at our institution, is defined as any patient, at
our or another hospital in the region, referred for surgery to
be carried out during the same admission. These patients are
managed on cardiac wards until the day before surgery
under the care of an independent consultant cardiologist,
and the waiting time varies from 1 to 14 days, on average.
This might have led to a difference in preoperative waiting
time between groups, and possibly to a difference in pneu-
monia/chest infection–induced PV, because a prolonged
preoperative in-hospital stay has been linked to hospital-
acquired infections.21 Finally, many potential actions could
be taken to minimize the incidence of reopening for bleed-
ing and tamponade including optimal hemostasis before
closure and a diagnosis-directed management of postoper-
ative coagulopathy.
This study is not without its limitations. First, there were
important preoperative imbalances between groups. Regres-
sion modeling and propensity score matching can never
entirely account for these imbalances, and the adjusted
estimates may still be subject to some residual confounding.
Nevertheless, such confounding is unlikely to change the
direction of the differences seen. Furthermore, in our insti-
1276 The Journal of Thoracic and Cardiovascular Surgery ● Novtution strict local guidelines are used to make decisions
about perioperative patient care, and these guidelines were
applied throughout the study period.
Conclusion
Our study suggests that PV is associated with high in-
hospital morbidity, mortality, and bed occupancy costs, and
significantly reduced 5-year survival. Given the limited
resources and the ever-increasing demand of medical care,
the independent predictors of PV identified by our study
may help to optimize the preoperative and postoperative
clinical management of these patients.
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